{"id":63175,"date":"2026-05-28T22:03:33","date_gmt":"2026-05-28T20:03:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/"},"modified":"2026-05-28T22:03:33","modified_gmt":"2026-05-28T20:03:33","slug":"lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/","title":{"rendered":"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference"},"content":{"rendered":"
\n

\nAfter receiving various types of therapy and treatments with little to no impact, clients credit Dehp\u00ae High with helping them evolve to higher states of being and cope with past trauma.<\/i><\/p>\n

BOSTON–(BUSINESS WIRE)–Go d\u0113hp\u00ae and d\u0113hp\u00ae Theraputic CEO Josette Sullins and Dr. Maria Navarro DBH, LPC, TAD, EMDR-C, Chief Behavioral Health Officer and Clinical Director of Go d\u0113hp\u00ae and d\u0113hp\u00ae Theraputic, are showcasing their proprietary Dehp\u00ae High treatment Friday, May 29, 2026, at the 37th Annual Boston International Trauma Conference. Attendees of the sponsored d\u0113hp Therapeutic Lunch and Learn during the conference will receive an introductory overview of the dIT and explore the stages of development within the d\u0113hp\u00ae model.<\/p>\n

<\/a>
<\/a><\/p>\n

\nd\u0113hp\u00ae stands for Develop Expression of Human Potential. Preliminary investigation has found dIT efficient and effective in treating certain types of stress and trauma. Clients credit the Dehp\u00ae High treatment with being pivotal in changing their lives for the better:<\/p>\n

\n\u201cThe Dehp High treatment was life-changing and revolutionary. In two hours, Josette could basically press the trauma out of my body,\u201d said Deb Placet, Manager\/Founder at RJP Estate Planning. \u201cI could see things more clearly and have hope for the future. Other treatments do not get to the fundamental problems and help you figure out how you can live a healthier and more successful life.\u201d<\/p>\n

\n\u201cBefore receiving the Dehp High treatment, my life felt like a disorganized basement of crunched and wet boxes. I tried therapy previously, but Dehp High was different. Josette did not try to be a cheerleader or dig in on one issue to diagnose me like I had previously experienced with therapists,\u201d said attorney Lisa Lanham. \u201cI had the space to learn to navigate through what was in those boxes, and now they are clear containers and organized, so I can open what I need to when I need to and then put it away.\u201d<\/p>\n

\nDehp\u00ae High is a non-drug proprietary treatment technique created to help recipients achieve clarity, peace and higher states of being. This interactive, experiential, sensory treatment is relaxing and allows the body, mind and spirit to reach lasting, natural, organic, higher states that are often not accessible or lasting with exercise, drugs, pharmaceuticals, or other treatments. Dehp\u00ae High is known for shifting the individual into a place referred to as Chronologically Current \u2122.<\/p>\n

\nTaking place May 27 to 30, 2026, at the Sheraton Boston Hotel, the 37th Annual Boston International Trauma Conference is hosted by the Trauma Research Foundation and Dr. Bessel van der Kolk. The d\u0113hp Therapeutic Lunch and Learn session is scheduled for 1:15 p.m. to 2:45 p.m. Eastern Standard Time.<\/p>\n

\nDehp\u00ae High training will take place in Boston later this year. Trauma care providers interested in becoming a d\u0113hp\u00ae Clinician can learn more at https:\/\/dehpcare.com\/licensed-professionals<\/a>.<\/p>\n

\nAbout Go d\u0113hp\u00ae<\/b><\/p>\n

\nFounded in 2014, d\u0113hp\u00ae Theraputic is a licensed behavioral health clinic. d\u0113hp\u00ae Theraputic and its therapists are licensed by the Arizona Department of Health Services. Go d\u0113hp\u00ae also operates clinics in Glendale and Tucson, and the 17th<\/sup> Floor luxurious penthouse clinic in Phoenix where physical, mental, and medical health care is offered in a 360-degree approach to full body, whole life wellness. For more information and to schedule a Dehp\u00ae High treatment, visit https:\/\/17thfloor.vip\/<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Laura Baumgartner
\n
Asylum Public Relations
\n
lbaumgartner@asylumpr.com<\/a>
855-462-7958<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

After receiving various types of therapy and treatments with little to no impact, clients credit Dehp\u00ae High with helping them evolve to higher states of being and cope with past trauma. BOSTON–(BUSINESS WIRE)–Go d\u0113hp\u00ae and d\u0113hp\u00ae Theraputic CEO Josette Sullins and Dr. Maria Navarro DBH, LPC, TAD, EMDR-C, Chief Behavioral Health Officer and Clinical Director … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-63175","format-standard","category-industry"],"yoast_head":"\nLifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"After receiving various types of therapy and treatments with little to no impact, clients credit Dehp\u00ae High with helping them evolve to higher states of being and cope with past trauma. BOSTON–(BUSINESS WIRE)–Go d\u0113hp\u00ae and d\u0113hp\u00ae Theraputic CEO Josette Sullins and Dr. Maria Navarro DBH, LPC, TAD, EMDR-C, Chief Behavioral Health Officer and Clinical Director ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T20:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260528605863\/en\/2817957\/22\/transparent_black_w_line.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference\",\"datePublished\":\"2026-05-28T20:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/\"},\"wordCount\":572,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260528605863\\\/en\\\/2817957\\\/22\\\/transparent_black_w_line.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/\",\"name\":\"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260528605863\\\/en\\\/2817957\\\/22\\\/transparent_black_w_line.jpg\",\"datePublished\":\"2026-05-28T20:03:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260528605863\\\/en\\\/2817957\\\/22\\\/transparent_black_w_line.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260528605863\\\/en\\\/2817957\\\/22\\\/transparent_black_w_line.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference - Pharma Trend","og_description":"After receiving various types of therapy and treatments with little to no impact, clients credit Dehp\u00ae High with helping them evolve to higher states of being and cope with past trauma. BOSTON–(BUSINESS WIRE)–Go d\u0113hp\u00ae and d\u0113hp\u00ae Theraputic CEO Josette Sullins and Dr. Maria Navarro DBH, LPC, TAD, EMDR-C, Chief Behavioral Health Officer and Clinical Director ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/","og_site_name":"Pharma Trend","article_published_time":"2026-05-28T20:03:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260528605863\/en\/2817957\/22\/transparent_black_w_line.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference","datePublished":"2026-05-28T20:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/"},"wordCount":572,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260528605863\/en\/2817957\/22\/transparent_black_w_line.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/","url":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/","name":"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260528605863\/en\/2817957\/22\/transparent_black_w_line.jpg","datePublished":"2026-05-28T20:03:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260528605863\/en\/2817957\/22\/transparent_black_w_line.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260528605863\/en\/2817957\/22\/transparent_black_w_line.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lifechanging-dehp-high-treatment-presented-at-the-37th-annual-boston-trauma-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lifechanging Dehp\u00ae High Treatment Presented at the 37th Annual Boston Trauma Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63175"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63175\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}